The BMEI found that discounts and competitive pricing are a powerful tool to boost product sales.
According to the BMEI, in order to conduct export business successfully, most SMEs attained product certifications from external entities to manage product quality standards and provide value-added services.
BMEI is the largest domestic Chinese supplier of radiation therapy systems with an installed base of around 260 units, a strong R&D focus and a team of highly skilled engineers.
BMEI brings to Elekta the ability to fully meet the needs of the Chinese and other emerging markets for affordable and lower cost radiation therapy solutions.
Our acquisition of BMEI should be seen as a part of the overall strategy to increase our presence in China and throughout Asia in terms of sales, marketing, manufacturing and R&D", says Tomas Puusepp, President and CEO of Elekta.
As a part of Elekta's long term growth strategy, and in order to complete the plans for developing BMEI into a competitive international supplier of modern equipment for radiation therapy, Elekta is planning for further investments into the Group's operations in China.
Elekta intends to integrate its existing technical and software solutions with BMEI equipment and technology to develop highly competitive and affordable radiation therapy solutions for the expanding need for treatment capacity in China and other emerging markets.
BMEI complements our current product range and will make it possible for us to address an important and growing segment of the market", says Gilbert Wai, Regional Vice President and head of Elekta's operations in China.
The operations of BMEI will be fully integrated into the Elekta Group both locally and globally and the acquisition of BMEI fits very well with Elekta's strategy to expand its sourcing and manufacturing platform in China.
Elekta plans to expand the operations of BMEI and invest up to SEK 50 M during the coming two years in R&D, manufacturing capacity and infrastructure.
Management plans include that BMEI, once integrated into the Elekta Group, will within 2 years launch major new and highly cost effective radiation therapy equipment aimed at for the domestic and international markets, complementing the existing Elekta portfolio.